EGFR and tuberculosis: Flavonoid-type compounds (e.g., GPM10, GPM15, GPM23) were predominantly associated with inflammation-related targets such as TNF, NOS2, EGFR, and IL2, and enriched in signaling pathways related to immune modulation and infection control, including cytokine signaling, tuberculosis, and influenza pathways.